The question underlying the work is one of the oldest in science: how could life have emerged from non-living matter? For a minimal cell to exist, Prof. Göpfrich explains, it must at least retain its genetic material while also being capable of change. Creating such a minimal living cell from scratch using non-living components is one of the central goals of synthetic biology, the field in which Göpfrich and her research group at the ZMBH work. Their chosen building blocks are RNA droplets: liquid-like, membrane-less nanostructures composed of synthetically produced ribonucleic acid that spontaneously self-assemble. Unlike conventional artificial cells enclosed in lipid membranes, these droplets rely on the intrinsic tendency of RNA molecules to condense into dense, viscous phases, much like oil droplets forming in water. That simplicity is precisely what makes them an attractive model for studying the earliest steps toward living systems.

A crucial property of these droplets is that they can encapsulate the genetic template from which they are transcribed. As William Verstraeten, a doctoral candidate in Prof. Göpfrich’s research group, notes, that establishes a basic prerequisite for a system that can evolve. The genetic blueprint and the molecular machinery reading it are held together in the same tiny compartment, so any mutation introduced into the template is immediately expressed as new RNA inside the very droplet that carries it. This coupling between genotype and phenotype at the nanoscale is something that even the simplest living cells achieve, and reproducing it in a purely synthetic, membrane-less system is a significant technical achievement in its own right.

What happened next surprised the researchers. When they deliberately modified the DNA template to introduce mutations, they expected the droplets to dissolve or lose their structural integrity. Instead, the opposite occurred: the droplets formed large cavities, known as vacuoles, which remained stable for days or even weeks. According to Göpfrich, a mutation rate of just around three percent was sufficient to produce these complex changes in the primitive synthetic cells. In other words, only a small fraction of the genetic material needed to be altered before the entire architecture of the droplet reorganized itself, sprouting internal compartments that no one had designed. The result suggests that elaborate structure can be encoded in, and triggered by, remarkably few molecular changes.

Identifying exactly which mutations were responsible required specialized expertise. The team led by Prof. Dr. Michael Platten at the German Cancer Research Center applied a specialized sequencing technology to determine which genetic changes produced the structural transformations inside the droplets. This analysis made it possible to create a model mutant, a defined genetic sequence whose introduction reliably reproduces the vacuole-forming effect. The ability to reproduce the phenotype at will transforms the observation from a curiosity into a tool: the researchers can now program droplet architecture by writing specific sequences into the template, effectively using mutation as a design language for synthetic cells.

The physical mechanism behind the cavities was worked out in collaboration with Prof. Dr. Christoph Weber from the Institute of Physics at the University of Augsburg. As he explains, the vacuoles form when more and more new RNA enters the already viscous interior of the droplets during transcription. The rapid accumulation of mass can cause local instabilities, from which the cavities form. In essence, the mutated RNA sequences produce transcripts that pile up inside the crowded droplet faster than the condensed phase can accommodate them, and the resulting mechanical stress tears open voids within the droplet body. The experiments confirmed that this process is subject to strict size and composition thresholds: vacuole formation requires RNA droplets to have a radius of more than 20 micrometers and to contain more than approximately two percent genetically modified material. Below those limits, the droplets remain homogeneous; above them, internal compartments reliably appear.

The consequences of those internal cavities extend far beyond appearance. Further investigations showed that the vacuoles redistribute mass inside the droplets, producing tiny movements on the micrometer scale. Mutated RNA droplets traveled significantly farther than their non-mutated counterparts and collided with one another more frequently. Those collisions had a consequential outcome: the droplets fused and grew. In a population of synthetic cells, therefore, the mutants are effectively more mobile and more interactive, qualities that in an evolutionary scenario could translate into a genuine advantage. The vacuoles also serve a storage function. As Göpfrich points out, they take up small molecules and can store this cargo inside them, giving the otherwise featureless droplets something analogous to internal organelles, compartments in which specific chemistry could in principle be concentrated and protected.

For Göpfrich, the deeper lesson is architectural. Mutagenesis, she emphasizes, provides a new architecture and new functions that would be very difficult to design and build from scratch. Traditional synthetic biology assembles systems part by part, an approach that becomes exponentially harder as the desired functions grow more complex. The Heidelberg results suggest an alternative strategy: encode a simple starting system, let mutations accumulate, and select the variants that acquire useful behaviors. Evolution, in this view, is not merely a subject of study but a manufacturing method, one capable of discovering structural solutions that human intuition and engineering would struggle to specify in advance.

That philosophy now anchors an ambitious applied agenda. As part of Heidelberg University’s SynthImmune Cluster of Excellence, the researchers aim to harness this process of mutation and selection to generate molecular functions from minimal synthetic components. Their stated goal is to use the tool to develop synthetic immune effectors capable of evolving specific immune functions on their own. If successful, the approach could yield therapeutic molecules that adapt within the body, refining their activity through cycles of mutation and selection rather than requiring every variant to be designed at the bench. The same principle, the researchers hope, could be extended to other medical applications where evolving function outperforms fixed design.

The work also carries conceptual weight for origins-of-life research. The experiments were conducted as part of the German Research Foundation-funded Collaborative Research Centre / Transregio 392, Molecular Evolution in Prebiotic Environments, which brings together the research groups of Kerstin Göpfrich in Heidelberg and Christoph Weber in Augsburg to study how evolutionary processes could have operated before cells existed. A system in which a few percent of mutations convert a static droplet into a mobile, compartmentalized, cargo-storing structure is a concrete demonstration that the threshold for emergent complexity can be low. The research was additionally supported by the European Research Council, the International Human Frontier Science Program Organization, the Alfried Krupp von Bohlen und Halbach Foundation and the Carl-Zeiss-Stiftung. The findings, published in Nature Chemical Engineering on 7 October 2026 under the title Genetic encoding and mutagenesis of RNA droplet phenotypes, suggest that the path from chemistry to function may be shorter, and more forgiving, than anyone had assumed.

Subject of Research: Mutation-driven emergence of complex phenotypes in synthetic RNA droplet cells

Article Title: Synthetic cells: function through mutation

Article References: Synthetic cells: function through mutation. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: synthetic cells, RNA droplets, mutation, vacuoles, synthetic biology, origin of life, molecular evolution, Heidelberg University, German Cancer Research Center, Nature Chemical Engineering, SynthImmune, cargo uptake